journal

JAMA Internal Medicine

journal
https://read.qxmd.com/read/31682713/trends-in-mortality-for-medicare-beneficiaries-treated-in-the-emergency-department-from-2009-to-2016
#1
Laura G Burke, Stephen K Epstein, Ryan C Burke, E John Orav, Ashish K Jha
Importance: Emergency department (ED) visits are common and increasing. Whether outcomes associated with care in the ED are improving over time is largely unknown to date. Objective: To examine trends in 30-day mortality rates associated with ED care among Medicare beneficiaries aged 65 years or older. Design, Setting, and Participants: This cross-sectional study used a random 5% sample in 2009 and 2010 and a 20% sample from 2011 to 2016, for a total of 15 416 385 ED visits from 2009 to 2016 among Medicare beneficiaries aged 65 years or older...
November 4, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31682682/comparison-of-group-medical-visits-combined-with-intensive-weight-management-vs-group-medical-visits-alone-for-glycemia-in-patients-with-type-2-diabetes-a-noninferiority-randomized-clinical-trial
#2
William S Yancy, Matthew J Crowley, Moahad S Dar, Cynthia J Coffman, Amy S Jeffreys, Matthew L Maciejewski, Corrine I Voils, Anna Barton Bradley, David Edelman
Importance: Traditionally, group medical visits (GMVs) for persons with diabetes improved glycemia by intensifying medications, which infrequently led to weight loss. Incorporating GMVs with intensive dietary change could enable weight loss and improve glycemia while decreasing medication intensity. Objective: To examine whether a program of GMVs combined with intensive weight management (WM) is noninferior to GMVs alone for change in glycated hemoglobin (HbA1c) level at 48 weeks (prespecified margin of 0...
November 4, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31682680/reflections-on-mortality-and-uncertainty-in-emergency-medicine
#3
Silas W Smith, David C Lee, Lewis R Goldfrank
No abstract text is available yet for this article.
November 4, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31682679/association-between-prescribed-opioids-and-infections-in-patients-neutropenia-and-cancer
#4
Carolin E M Jakob, Melanie Stecher, Annika Y Claßen, Axel Hamprecht, Oliver A Cornely, Jörg J Vehreschild
No abstract text is available yet for this article.
November 4, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31682677/advanced-care-planning-what-should-i-know
#5
John Landefeld, Michael A Incze
No abstract text is available yet for this article.
November 4, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31682676/mind-body-therapies-for-opioid-treated-pain-a-systematic-review-and-meta-analysis
#6
Eric L Garland, Carrie E Brintz, Adam W Hanley, Eric J Roseen, Rachel M Atchley, Susan A Gaylord, Keturah R Faurot, Joanne Yaffe, Michelle Fiander, Francis J Keefe
Importance: Mind-body therapies (MBTs) are emerging as potential tools for addressing the opioid crisis. Knowing whether mind-body therapies may benefit patients treated with opioids for acute, procedural, and chronic pain conditions may be useful for prescribers, payers, policy makers, and patients. Objective: To evaluate the association of MBTs with pain and opioid dose reduction in a diverse adult population with clinical pain. Data Sources: For this systematic review and meta-analysis, the MEDLINE, Embase, Emcare, CINAHL, PsycINFO, and Cochrane Library databases were searched for English-language randomized clinical trials and systematic reviews from date of inception to March 2018...
November 4, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31682674/women-s-roles-and-barriers-to-leadership-in-the-national-collegiate-athletic-association
#7
Ann M Sheehy, Peter Miller, Molly Carnes
No abstract text is available yet for this article.
November 4, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31682672/distribution-of-men-and-women-among-ncaa-head-team-physicians-head-athletic-trainers-and-assistant-athletic-trainers
#8
Caitlin Lewis, Yuxuan Jin, Carly Day
No abstract text is available yet for this article.
November 4, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31657846/the-culture-of-trial-results-reporting-at-academic-medical-centers
#9
Deborah A Zarin
No abstract text is available yet for this article.
October 28, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31657845/the-human-costs-of-medicare-fraud-and-abuse
#10
Joseph S Ross
No abstract text is available yet for this article.
October 28, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31657844/private-rights-and-the-public-interest-in-drug-and-medical-device-litigation
#11
I Glenn Cohen, Nicholas Bagley
No abstract text is available yet for this article.
October 28, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31657843/confronting-bias-and-discrimination-in-health-care-when-silence-is-not-golden
#12
Lisa A Cooper, Mary Catherine Beach, David R Williams
No abstract text is available yet for this article.
October 28, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31657842/the-clinical-trials-portfolio-for-on-label-and-off-label-studies-of-eculizumab
#13
Myung S Kim, Vinay Prasad
No abstract text is available yet for this article.
October 28, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31657841/time-from-submission-of-johns-hopkins-university-trial-results-to-posting-on-clinicaltrials-gov
#14
Anthony Keyes, Evan Mayo-Wilson, Nidhi Atri, Aliya Lalji, Prince S Nuamah, Oswald Tetteh, Daniel E Ford
No abstract text is available yet for this article.
October 28, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31657840/association-of-a-workplace-sales-ban-on-sugar-sweetened-beverages-with-employee-consumption-of-sugar-sweetened-beverages-and-health
#15
Elissa S Epel, Alison Hartman, Laurie M Jacobs, Cindy Leung, Michael A Cohn, Leeane Jensen, Laura Ishkanian, Janet Wojcicki, Ashley E Mason, Robert H Lustig, Kimber L Stanhope, Laura A Schmidt
Importance: Reductions in sugar-sweetened beverage (SSB) intake can improve health, but are difficult for individuals to achieve on their own. Objectives: To evaluate whether a workplace SSB sales ban was associated with SSB intake and cardiometabolic health among employees and whether a brief motivational intervention provides added benefits to the sales ban. Design, Setting, and Participants: This before-after study and additional randomized trial conducted from July 28, 2015, to October 16, 2016, at a Northern California university and hospital assessed SSB intake, anthropometrics, and cardiometabolic biomarkers among 214 full-time English-speaking employees who were frequent SSB consumers (≥360 mL [≥12 fl oz] per day) before and 10 months after implementation of an SSB sales ban in a large workplace, with half the employees randomized to receive a brief motivational intervention targeting SSB reduction...
October 28, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31657839/physician-and-trainee-experiences-with-patient-bias
#16
Margaret Wheeler, Shalila de Bourmont, Kimani Paul-Emile, Alana Pfeffinger, Ashley McMullen, Jeff M Critchfield, Alicia Fernandez
Importance: As the clinical workforce becomes more diverse, physicians encounter patients who demean them based on social characteristics. Little is known about physicians' perspectives on these encounters and their effects. This knowledge would help develop policies and best practices for institutions and training programs. Objective: To describe the range and importance of encounters with biased patients and the barriers and facilitators to effective responses...
October 28, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31657838/association-between-treatment-by-fraud-and-abuse-perpetrators-and-health-outcomes-among-medicare-beneficiaries
#17
Lauren Hersch Nicholas, Caroline Hanson, Jodi B Segal, Matthew D Eisenberg
Importance: Fraud and abuse contribute to unnecessary spending in the Medicare program, and federal agencies have prioritized fund recovery and the exclusion of health care practitioners who violate policy. However, the human costs of fraud and abuse in terms of patient health are unknown. Objective: To assess whether Medicare beneficiaries' receipt of health care services from fraud and abuse perpetrators (FAPs) is associated with worse health outcomes. Design, Setting, and Participants: Retrospective cross-sectional study comparing mortality and emergency hospitalization rates of 8204 patients treated by an FAP with those among patients treated by a randomly selected non-FAP in 2013...
October 28, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31657836/confidentiality-orders-and-public-interest-in-drug-and-medical-device-litigation
#18
Alexander C Egilman, Aaron S Kesselheim, Harlan M Krumholz, Joseph S Ross, Jeanie Kim, Amy Kapczynski
Litigation involving drug and medical device manufacturers has the potential to reveal important information about product efficacy and safety as well as company marketing. Prevailing legal standards recognize the public's interest in having access to certain types of information in lawsuits. However, in practice, courts and litigants commonly use overly broad or unwarranted confidentiality orders, which can prevent the public from accessing important public health information that emerges during litigation...
October 28, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31633747/including-the-family-in-perioperative-care-of-older-adults-a-call-for-help
#19
Victoria Tang, Emily Finlayson, Ken Covinsky
No abstract text is available yet for this article.
October 21, 2019: JAMA Internal Medicine
https://read.qxmd.com/read/31633746/effect-of-depression-screening-after-acute-coronary-syndromes-on-quality-of-life-the-codiacs-qol-randomized-clinical-trial
#20
Ian M Kronish, Nathalie Moise, Ying Kuen Cheung, Gregory N Clarke, Rowena J Dolor, Joan Duer-Hefele, Karen L Margolis, Tara St Onge, Faith Parsons, Jessica Retuerto, Anusorn Thanataveerat, Karina W Davidson
Importance: Patients with acute coronary syndrome (ACS) and elevated depressive symptoms are at increased risk for recurrent cardiovascular events and mortality, worse quality of life, and higher health care costs. These observational findings prompted multiple scientific panels to advise universal depression screening in survivors of ACS prior to evidence from randomized screening trials. Objective: To determine whether systematically screening for depression in survivors of ACS improves quality of life and depression compared with usual care...
October 21, 2019: JAMA Internal Medicine
journal
journal
44128
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"